A Correlation Between the In Vitro Drug Toxicity of Drugs to Cell Lines That Express Human P450s and Their Propensity to Cause Liver Injury in Humans
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Drug toxicity to T-antigen-immortalized human liver epithelial (THLE) cells stably transfected with plasmid vectors that encoded human cytochrome P450s 1A2, 2C9, 2C19, 2D6, or 3A4, or an empty plasmid vector (THLE-Null), was investigated. An automated screening platform, which included 1% dimethyl sulfoxide (DMSO) vehicle, 2.7% bovine serum in the culture medium, and assessed 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium reduction, was used to evaluate the cytotoxicity of 103 drugs after 24h. Twenty-two drugs caused cytotoxicity to THLE-Null cells, with EC₅₀ ≤ 200 μM; 21 of these drugs (95%) have been reported to cause human liver injury. Eleven drugs exhibited lower EC₅₀ values in cells transfected with CYP3A4 (THLE-3A4 cells) than in THLE-Null cells; 10 of these drugs (91%) caused human liver injury. An additional 8 drugs, all of which caused human liver injury, exhibited potentiated THLE-3A4 cell toxicity when evaluated using a manual protocol that included 0.2% or 1% DMSO, but not bovine serum. Fourteen of the drugs that exhibited potentiated THLE-3A4 cell toxicity are known to be metabolized by P450s to reactive intermediates. These drugs included troglitazone, which was shown to undergo metabolic bioactivation and covalent binding to proteins in THLE-3A4 cells. A single drug (rimonabant) exhibited marked THLE cell toxicity but did not cause human liver injury; this drug had very low reported plasma exposure. These results indicate that evaluation of toxicity to THLE-Null and THLE-3A4 cell lines during drug discovery may aid selection of drugs with reduced propensity to cause drug-induced liver injury and that consideration of human exposure is required to enhance data interpretation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, few of the models contain the full complement and functionality of metabolic enzymes and transporters present in human hepatocytes in vivo (Gustafsson et al. 2014; Wilkening and Bader 2003), which is also true with plated primary human hepatocytes (PHH) that rapidly loose liver phenotype and CYP450 activity in traditional monolayer cultures (Rodriguez-Antona et al. 2002).”
From Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury (2017) · cites this paper as Gustafsson et al. 2014
Citations
Cites
Abboud, G., & Kaplowitz, N. (2007) · Drug Safety · doi:10.2165/00002018-200730040-00001 · Cited by 479
Managing the challenge of chemically reactive metabolites in drug development
Park, B. K., Boobis, A., Clarke, S., Goldring, C. E. P., Jones, D., Kenna, J. G., Lambert, C., Laverty, H. G., Naisbitt, D. J., Nelson, S., et al. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3408 · Cited by 462
Self-citationThe significance of mitochondrial toxicity testing in drug development
Dykens, J. A., & Will, Y. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.07.013 · Cited by 416
FDA-approved drug labeling for the study of drug-induced liver injury
Chen, M., Vijay, V., Shi, Q., Liu, Z., Fang, H., & Tong, W. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.05.007 · Cited by 406
Dawson, S., Stahl, S., Paul, N., Barber, J., & Kenna, J. G. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.040758 · Cited by 343
Self-citationKassahun, K., Pearson, P. G., Tang, W., McIntosh, I., Leung, K., Elmore, C., Dean, D., Wang, R., Doss, G., & Baillie, T. A. (2001) · Chemical Research in Toxicology · doi:10.1021/tx000180q · Cited by 311
Nakayama, S., Atsumi, R., Takakusa, H., Kobayashi, Y., Kurihara, A., Nagai, Y., Nakai, D., & Okazaki, O. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.027797 · Cited by 251
Pfeifer, A. M., Cole, K. E., Smoot, D. T., Weston, A., Groopman, J. D., Shields, P. G., Vignaud, J. M., Juillerat, M., Lipsky, M. M., & Trump, B. F. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5123 · Cited by 242
Mace, K. (1997) · Carcinogenesis · doi:10.1093/carcin/18.7.1291 · Cited by 224
Thompson, R. A., Isin, E. M., Li, Y., Weidolf, L., Page, K., Wilson, I., Swallow, S., Middleton, B., Stahl, S., Foster, A. J., et al. (2012) · Chemical Research in Toxicology · doi:10.1021/tx300091x · Cited by 213
Self-citation
Cited by
Chen, M., Suzuki, A., Thakkar, S., Yu, K., Hu, C., & Tong, W. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.02.015 · Cited by 398
Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury
Proctor, W. R., Foster, A. J., Vogt, J., Summers, C., Middleton, B., Pilling, M. A., Shienson, D., Kijanska, M., Ströbel, S., Kelm, J. M., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2002-1 · Cited by 328
“2008), or cell viability assessment in SV-40 transformed human liver epithelial (THLE) cells (Dambach et al. 2005; Gustafsson et al. 2014).”
BackgroundInfluentialSelf-citationCompetency of different cell models to predict human hepatotoxic drugs
Gómez-Lechón, M. J., Tolosa, L., Conde, I., & Donato, M. T. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.967680 · Cited by 199
“Such THLE-based screenings have shown high specificity and acceptable sensitivity to discriminate between drugs reported as being hepatotoxic, or not, to humans [82,83].”
BackgroundMethodInfluentialVorrink, S. U., Zhou, Y., Ingelman-Sundberg, M., & Lauschke, V. M. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy058 · Cited by 187
Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability
Hendriks, D. F. G., Fredriksson Puigvert, L., Messner, S., Mortiz, W., & Ingelman-Sundberg, M. (2016) · Scientific Reports · doi:10.1038/srep35434 · Cited by 156
Reactive Metabolites: Current and Emerging Risk and Hazard Assessments
Thompson, R. A., Isin, E. M., Ogese, M. O., Mettetal, J. T., & Williams, D. P. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00410 · Cited by 140
Thakkar, S., Li, T., Liu, Z., Wu, L., Roberts, R., & Tong, W. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2019.09.022 · Cited by 140
Predicting Drug-Induced Liver Injury with Bayesian Machine Learning
Williams, D. P., Lazic, S. E., Foster, A. J., Semenova, E., & Morgan, P. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00264 · Cited by 124
Self-citationKohonen, P., Parkkinen, J. A., Willighagen, E. L., Ceder, R., Wennerberg, K., Kaski, S., & Grafström, R. C. (2017) · Nature Communications · doi:10.1038/ncomms15932 · Cited by 110
Sison-Young, R. L., Lauschke, V. M., Johann, E., Alexandre, E., Antherieu, S., Aerts, H., Gerets, H. H. J., Labbe, G., Hoët, D., Dorau, M., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-016-1745-4 · Cited by 104
Hong, H., Thakkar, S., Chen, M., & Tong, W. (2017) · Scientific Reports · doi:10.1038/s41598-017-17701-7 · Cited by 99
Garside, H., Marcoe, K. F., Chesnut-Speelman, J., Foster, A. J., Muthas, D., Gerry Kenna, J., Warrior, U., Bowes, J., & Baumgartner, J. (2014) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.10.015 · Cited by 93
Self-citationWalker, P. A., Ryder, S., Lavado, A., Dilworth, C., & Riley, R. J. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02763-w · Cited by 90
Gómez‐Lechón, M. J., Tolosa, L., & Donato, M. T. (2015) · Journal of Applied Toxicology · doi:10.1002/jat.3277 · Cited by 95
Wink, S., Hiemstra, S. W., Huppelschoten, S., Klip, J. E., & van de Water, B. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2178-z · Cited by 80
Advantageous use of HepaRG cells for the screening and mechanistic study of drug-induced steatosis
Tolosa, L., Gómez‐Lechón, M. J., Jiménez, N., Hervás, D., Jover, R., & Donato, M. T. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.04.007 · Cited by 81
Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction
Segovia-Zafra, A., Di Zeo-Sánchez, D. E., López-Gómez, C., Pérez-Valdés, Z., García-Fuentes, E., Andrade, R. J., Lucena, M. I., & Villanueva-Paz, M. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.11.013 · Cited by 70
SynToxProfiler: An interactive analysis of drug combination synergy, toxicity and efficacy
Ianevski, A., Timonen, S., Kononov, A., Aittokallio, T., & Giri, A. K. (2020) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1007604 · Cited by 68
Immortalized Human Hepatic Cell Lines for In Vitro Testing and Research Purposes
Ramboer, E., Vanhaecke, T., Rogiers, V., & Vinken, M. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2074-7_4 · Cited by 61
Thakkar, S., chen, M., Fang, H., Liu, Z., Roberts, R., & Tong, W. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1383154 · Cited by 61
Atienzar, F. A., Blomme, E. A., Chen, M., Hewitt, P., Kenna, J. G., Labbe, G., Moulin, F., Pognan, F., Roth, A. B., Suter-Dick, L., et al. (2016) · BioMed Research International · doi:10.1155/2016/9737920 · Cited by 59
Self-citationAleo, M. D., Shah, F., Allen, S. W., Barton, H. A., Costales, C., Lazzaro, S., Leung, L. Y., Nilson, A. L., Obach, R. S., Rodrigues, A. D., et al. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00262 · Cited by 58
An Automated Multiplexed Hepatotoxicity and CYP Induction Assay Using HepaRG Cells in 2D and 3D
Ott, L. M., Ramachandran, K., & Stehno-Bittel, L. (2017) · SLAS Discovery · doi:10.1177/2472555217701058 · Cited by 55
Hiemstra, S., Ramaiahgari, S. C., Wink, S., Callegaro, G., Coonen, M., Meerman, J., Jennen, D., van den Nieuwendijk, K., Dankers, A., Snoeys, J., et al. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02552-0 · Cited by 53
High-content screening of drug-induced mitochondrial impairment in hepatic cells: effects of statins
Tolosa, L., Carmona, A. L., Castell, J. V., Gómez‐Lechón, M. J., & Donato, M. T. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1334-3 · Cited by 55
Boncler, M. A., Golański, J., Lukasiak, M., Redzynia, M., Dastych, J., & Watała, C. W. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180022 · Cited by 50
Bannaga, A., Tyagi, H., Daulton, E., Covington, J. A., & Arasaradnam, R. P. (2021) · Molecules · doi:10.3390/molecules26092447 · Cited by 50
Kenna, J. G., Stahl, S. H., Eakins, J. A., Foster, A. J., Andersson, L. C., Bergare, J., Billger, M., Elebring, M., Elmore, C. S., & Thompson, R. A. (2015) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.220491 · Cited by 48
“The value of these cell lines for investigation of P450-independent and P450 metabolite-mediated cell toxicity has been demonstrated previously (Foster et al., 2013; Gustafsson et al., 2014).”
BackgroundInfluentialSelf-citationJia, X., Wen, X., Russo, D. P., Aleksunes, L. M., & Zhu, H. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2022.129193 · Cited by 49
Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays
Roth, A. D., & Lee, M. (2017) · BioMed Research International · doi:10.1155/2017/9176937 · Cited by 54
Tolosa, L., Jiménez, N., Pérez, G., Castell, J. V., Gómez-Lechón, M. J., & Donato, M. T. (2018) · Archives of Toxicology · doi:10.1007/s00204-017-2036-4 · Cited by 44
Barber, J. A., Stahl, S. H., Summers, C., Barrett, G., Park, B. K., Foster, J. R., & Kenna, J. G. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv159 · Cited by 39
Self-citationMultiparametric assay using HepaRG cells for predicting drug-induced liver injury
貴文, 富., Okamura, H., Satsukawa, M., Yokoi, T., & Konno, Y. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.04.014 · Cited by 41
Kalgutkar, A. S. S. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00332 · Cited by 37
Yu, K., Nadanaciva, S., Rana, P., Lee, D. W., Ku, B., Roth, A., Dordick, J. S., Will, Y., & Lee, M. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2126-3 · Cited by 35
Li, R., Liu, J., Ma, J., Sun, X., Wang, Y., Yan, J., Yu, Q., Diao, J., Yang, C., Reid, L. M., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2021.121266 · Cited by 30
Do In Vitro Assays Predict Drug Candidate Idiosyncratic Drug-Induced Liver Injury Risk?
Kenna, J. G., & Uetrecht, J. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.082719 · Cited by 32
Self-citationHong, H., Zhu, J., Chen, M., Gong, P., Zhang, C., & Tong, W. (2018) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-7677-5_5 · Cited by 30
Xu, J., Oda, S., & Yokoi, T. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.01.019 · Cited by 26
Gómez-Lechón, M. J., Tolosa, L., & Donato, M. T. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1238459 · Cited by 27
Koh, B., & Kim, E.-A. (2019) · Environmental Pollution · doi:10.1016/j.envpol.2019.113156 · Cited by 25
In vitro cell-based models of drug-induced hepatotoxicity screening: progress and limitation
Mirahmad, M., Sabourian, R., Mahdavi, M. R., Larijani, B. A., & Safavi, M. (2022) · Drug Metabolism Reviews · doi:10.1080/03602532.2022.2064487 · Cited by 24
Machine Learning Models for Predicting Liver Toxicity
Liu, J., Guo, W., Sakkiah, S., Ji, Z., Yavaş, G., Zou, W., Chen, M., Tong, W., Patterson, T. A., & Hong, H. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1960-5_15 · Cited by 23
Evaluation of CYP3A4 inhibition and hepatotoxicity using DMSO-treated human hepatoma HuH-7 cells
Liu, Y., Flynn, T. J., Xia, M., Wiesenfeld, P. L., & Ferguson, M. S. (2015) · Cell Biology and Toxicology · doi:10.1007/s10565-015-9306-9 · Cited by 27
A large-scale human toxicogenomics resource for drug-induced liver injury prediction
Bergen, V., Kodella, K. R., Srikrishnan, S., Barrandon, O., Anderson, S., Rogers-Grazado, M., Fowler, C. C., Beyene, H., Robichaud, N., Fulton, T., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65690-3 · Cited by 33
貴文, 富., Okamura, H., Yokoi, T., & Konno, Y. (2016) · Journal of Applied Toxicology · doi:10.1002/jat.3371 · Cited by 19
Long-acting GnRH analogue triptorelin therapy in central isosexual precocious puberty.
Bajpai, A., Sharma, J. N., Kabra, M., Gupta, A. K., & Menon, P. S. N. (2002) · PubMed · Cited by 19
The Use of Gene Ontology Term and KEGG Pathway Enrichment for Analysis of Drug Half-Life
Zhang, Y., Chu, C., Wang, S., Chen, L., Lu, J., Kong, X., Huang, T., Li, H., & Cai, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165496 · Cited by 18
Stieger, B., & Mahdi, Z. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.03.023 · Cited by 19
Use of Liver-Derived Cell Lines for the Study of Drug-Induced Liver Injury
Ren, Z., Chen, S., Ning, B., & Guo, L. (2018) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-7677-5_8 · Cited by 24
Latest impact of engineered human liver platforms on drug development
Monckton, C. P., Brown, G. E., & Khetani, S. R. (2021) · APL Bioengineering · doi:10.1063/5.0051765 · Cited by 18
Cell-based models to predict human hepatotoxicity of drugs
Gómez-Lechón, M., Tolosa, L., & Donato, M. T. (2014) · Revista de toxicología · Cited by 23
Donato, M. T., Jiménez, N., Pelechá-Salvador, M., & Tolosa, L. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03236-y · Cited by 15
Fluoroquinolones and propionic acid derivatives induce inflammatory responses in vitro
Nakajima, A., Sato, H., Oda, S., & Yokoi, T. (2017) · Cell Biology and Toxicology · doi:10.1007/s10565-017-9391-z · Cited by 11
Drug-Induced Liver Injury (DILI) Classification and Its Application on Human DILI Risk Prediction
Thakkar, S., Chen, M., Hong, H., Liu, Z., Fang, H., & Tong, W. (2018) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-7677-5_3 · Cited by 8
Kenna, J. G. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1290082 · Cited by 7
Self-citationZebrafish toxicological screening could aid Leishmaniosis drug discovery
Fukushima, H. C. S., Bailone, R. L., Corrêa, T., Janke, H., de Aguiar, L. K., Setti, P. G., & Borra, R. C. (2021) · Laboratory Animal Research · doi:10.1186/s42826-021-00104-1 · Cited by 7
Status and Future of 3D Cell Culture in Toxicity Testing
Otieno, M. A., Gan, J., & Proctor, W. R. (2018) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-7677-5_12 · Cited by 6
Integration of in vitro and in silico approaches enables prediction of drug-induced liver injury
Geci, R., Sayin, A. Z., Schaller, S., & Kuepfer, L. (2026) · Archives of Toxicology · doi:10.1007/s00204-026-04305-2 · Cited by 7
Light, D. S., Aleo, M. D., & Kenna, J. G. (2018) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-7677-5_17 · Cited by 6
Self-citationA novel in vitro high-content imaging assay for the prediction of drug-induced lung toxicity
Fitzpatrick, P. A., Johansson, J., Maglennon, G. A., Wallace, I., Hendrickx, R., Stamou, M., Sivars, K. B., Busch, S., Johansson, L., van Zuydam, N. R., et al. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03800-8 · Cited by 5
Qin, Z., Zhao, L., Hu, H., Jiang, H., Yu, L., & Zeng, S. (2016) · Xenobiotica · doi:10.1080/00498254.2016.1211774 · Cited by 4
Weyers, C., Dingle, L. M. K., Wilhelmi, B., Edkins, A., & Veale, C. G. L. (2020) · Drug and chemical toxicology (New York, N.Y. 1978) · doi:10.1080/01480545.2019.1585869 · Cited by 1
Kenna, J. G., Persson, M., Siler, S. Q., Yu, K., Hu, C., Chen, M., Xu, J., Tong, W., Will, Y., & Aleo, M. D. (2016) · Wiley eBooks · doi:10.1002/9781119053248.ch8 · Cited by 3
Self-citationThe role of drug metabolism in drug discovery and development : case ospemifene
Uusitalo, J. (2015) · Cited by 2
Leading-Edge Approaches for In Vitro Hepatotoxicity Evaluation
LeCluyse, E. L., Norona, L. M., Akingbasote, J. A., Howell, L. S., Woodhead, J. L., Cross, M. J., Roth, A. B., & Goldring, C. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64267-8 · Cited by 2
Huang, L., Zou, S.-X., Deng, J., Dai, T., Jiang, J., Jia, Y., Dai, R., & Xie, S. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2015.12.008 · Cited by 2
High-Content Screening: Understanding and Managing Mechanistic Data to Better Predict Toxicity
Walker, P., Smith, T., Frost, K., Kelly, S., & Suarez, I. G. (2015) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-2778-4_13 · Cited by 1
Predicting the Risks of Drug-Induced Liver Injury in Humans Utilizing Computational Modeling
Chen, M., Zhu, J., Ashby, K., Wu, L., Liu, Z., Gong, P., Zhang, C., Borlak, J. T., Hong, H., & Tong, W. (2019) · Challenges and advances in computational chemistry and physics · doi:10.1007/978-3-030-16443-0_13 · Cited by 1
In Vitro Models for the Prediction of Drug‐Induced Liver Injury in Lead Discovery
Moulin, F., & Flint, O. P. (2015) · Methods and principles in medicinal chemistry · doi:10.1002/9783527673643.ch07 · Cited by 2
INTEGRATED REACTIVE METABOLITE STRATEGIES
Kenna, J. G., & Thompson, R. A. (2016) · Wiley eBooks · doi:10.1002/9781118949689.ch5 · Cited by 1
Self-citationSeurat-1: HepaRG, repeated and single dose exposure for Mitochondrial Health and LipidTox
Joossens, E., Bories, G., Thomas, C., Salvador, F. T., Gineste, J.-M., Horvat, T., David, C. J., Lostia, A. M., Peter, M., Jaroslav, N., et al. (2015) · Joint Research Centre (European Commission) · doi:10.2788/15188
Rana, P. (2020) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/rana-payal-2020
Recent Advances in Volatile Organic Compound Analysis as Diagnostic Biomarkers
Drabińska, N., & Lacy Costello, B. D. (2022) · MDPI eBooks · doi:10.3390/books978-3-0365-5349-8
Space of Disse on Chip Model for Study of Hepatic Toxicity and Inflammation
Mesic, A. (2025) · theses.fr (ABES) · doi:10.70675/4c19917ez1d50z4ac8za1a5zd5c8d942f244
Liver lobule models incorporating the space of Disse and their applications
Mesic, A., Bensalem, S., Pioufle, B. L., Duclos‐Vallée, J., & Messina, A. (2026) · Biomicrofluidics · doi:10.1063/5.0331517
Norona, L. M., Melnikov, F., Kiyota, T., Lawson, C., Khojasteh, C., Liu, J., Johnson, K. M., Pourmohamad, T., Anger, L. T., Proctor, W. R., et al. (2026) · Toxicological Sciences · doi:10.1093/toxsci/kfag124
Metadata
- Authors
- Gustafsson, F., Foster, A. J., Sarda, S., Bridgland-Taylor, M. H., & Kenna, J. G.
- Affiliations
- AstraZeneca (United Kingdom) (GB)
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-10-01
- Volume
- 137
- Issue
- 1
- Pages
- 189-211
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- OpenAlex
- W2145394548
- Cited by
- 77
- References
- 40
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 1 · 2022: 5 · 2021: 5 · 2020: 3 · 2019: 7 · 2018: 9 · 2017: 13 · 2016: 13 · 2015: 9 · 2014: 5 · 2013: 1
- FWCI
- 10.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Toxicological Sciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Nestec
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Keywords
- drug-induced liver injury, hepatotoxicity, human cytochrome P450, CYP3A4, cytotoxicity, drug metabolism, reactive metabolites, troglitazone, rimonabant, plasma exposure
- MeSH terms
- Biological Assay, Biotransformation, Cell Line, Cell Survival, Cytochrome P-450 Enzyme System, Dose-Response Relationship, Drug, Epithelial Cells, Humans, Liver, Risk Factors, Transfection, Risk Assessment, Toxicity Tests, Inhibitory Concentration 50, Chemical and Drug Induced Liver Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.